
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Divalproex Sodium (Depakote)
Levetiracetam
Lamotrigine (Lamictal)
Gabapentin
More Pediatric Epilepsy Medications






